CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue:
Total net revenue	$ 61,680	$ 48,643	$ 181,146	$ 147,697
Operating expenses:
Research and development	0	311	0	1,013
General and administrative	4,019	8,310	17,415	29,489
General and administrative - related party	0	0	2,700	0
Total operating expenses	4,019	8,621	20,115	30,502
Income from operations	57,661	40,022	161,031	117,195
Other expense, net	(2,626)	(6,369)	(5,686)	(7,108)
Interest income	370	376	1,141	918
Interest expense	(5,238)	(10,262)	(19,373)	(35,247)
Net income	50,167	23,767	137,113	75,758
Net income attributable to noncontrolling interest	3,078	0	5,817	0
Net income attributable to Innoviva stockholders	$ 47,089	$ 23,767	$ 131,296	$ 75,758
Basic net income per share attributable to Innoviva stockholders	$ 0.47	$ 0.22	$ 1.30	$ 0.71
Diluted net income per share attributable to Innoviva stockholders	$ 0.43	$ 0.21	$ 1.19	$ 0.67
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	100,936	106,841	100,806	107,236
Shares used to compute diluted net income per share	113,363	119,796	113,444	120,120
Royalty revenue from a related party
Revenue:
Total net revenue	$ 61,680	$ 48,422	$ 181,146	$ 147,034
Revenue from collaborative arrangements from a related party
Revenue:
Total net revenue	$ 0	$ 221	$ 0	$ 663